Women with obesity and endometrial cancer who lose weight in advance of surgery have fewer complications and shorter hospital stays, according to preliminary study results so promising that they are already changing the standard ...
Feb 15, 2022
0
0
No single gene causes uterine cancer, the fourth most common cancer among women, which is on the rise in the U.S.
Jan 28, 2022
0
0
A team of scientists led by the University of Michigan Health Rogel Cancer Center has found that a class of U.S. Food and Drug Administration-approved drugs can effectively stop a highly aggressive type of uterine cancer ...
Dec 17, 2021
0
17
Uterine cancers that developed in patients treated with tamoxifen (Soltamox) had fewer PI3K pathway mutations and may have instead been driven by tamoxifen-induced PI3K pathway activation, according to results presented at ...
Dec 9, 2021
0
2
Gynecologic cancer is the growth and spread of cancer cells in the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva as well as in peritoneum—also known as the reproductive organs, which make any woman at risk ...
Sep 8, 2021
0
3
New research being presented at The European Congress on Obesity (ECO) held online this year, suggests that a measure of body shape should be used alongside body mass index (BMI) to help determine the risk of obesity-related ...
May 10, 2021
0
4
In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS). Furthermore, using fully sequenced patient-derived xenografts, the team has preclinically validated new ...
Apr 5, 2021
0
24
A hydrogel developed at Hokkaido University successfully reverted cancer cells back to cancer stem cells within 24 hours in six different human cancer types. This could lead to the development of anti-cancer stem cell drugs ...
Mar 29, 2021
0
412
(HealthDay)—Aspirin use may improve survival for bladder and breast cancer, according to a study published online Jan. 15 in JAMA Network Open.
Jan 27, 2021
0
7
A new study by University of Kentucky Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials ...
Jan 12, 2021
0
7
